Current Headlines

1. Frost & Sullivan's GIL 2013: Europe Set the Stage for a More Positive Economic Outlook
   5/17/2013

   Frost & Sullivan's GIL 2013: Europe - The Global Community of Growth, Innovation and Leadership annual congress, which set the stage for a new and more positive economic outlook which was confirmed yesterday by the encouraging predictions from the Bank of England.

2. Emergent Technologies And Caisson Biotech Form Strategic Alliance With Local Health Care Providers To Improve Delivery And Performance Of A Therapeutic Drug
   5/1/2013

   Emergent Technologies, Inc. and portfolio company, Caisson Biotech, LLC, developer of the novel HEPtune^TM drug delivery system, are teaming with Seton Healthcare Family and the research group of Dr. T.J. Milling to modify a therapeutic drug in order to increase its performance and safety and improve patient experience and outcomes

3. Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
   4/30/2013

   Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the US market launch of its proprietary new test, PROMETHEUS® Anser™ ADA

4. Afraxis, Inc. And Servier Announce A Collaboration On ESP Platform For Drug Discovery In Central Nervous System Disorders
   4/30/2013

   Afraxis, Inc. ("Afraxis") and Institut de Recherches Servier ("Servier") announced a non-exclusive platform collaboration using Afraxis' Enhanced Spine Platform (ESP) Technology for the discovery of drugs to treat central nervous system (CNS) disorders

5. Sensile Medical Enters Into An Agreement With scPharmaceuticals For Advanced Subcutaneous Drug Delivery System
   4/30/2013

   Sensile Medical AG has entered into a strategic partnership and supply agreement with scPharmaceuticals LLC to develop and manufacture an automated patch pump that delivers furosemide subcutaneously

6. Pharmaco-Kinesis Corporation Develops First Combinatorial Nano-Drug TNT
   4/30/2013

   Pharmaco-Kinesis Corporation (PKC), an advanced medical device company developing smart implantable pumps and medications for local drug delivery, recently reported development of the first combinatorial nano-drug product candidate, a combination of Temozolomide (Merck & Co.) and Thalidomide (Celgene) nanoparticles to be tested for treatment of gliomas and other cancers

7. Evotec Extends Drug Discovery Alliance With Genentech
   4/22/2013

   Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has extended its drug discovery alliance with Genentech, a member of the Roche Group (SIX:RO) (ROG) (OTCQX:RHHBY), for three additional years

8. FDA Advisory Committee Recommends Approval Of BREO™ ELLIPTA™ For The Treatment Of COPD
   4/17/2013

   GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the US Food and Drug Administration (FDA) voted that the efficacy and safety data provide substantial evidence to support approval of BREO™ ELLIPTA™ as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against)

9. Patheon to Feature its Complex Formulation Technologies Expertise
   4/15/2013

   Patheon personnel will be available to meet at the CPhI/ICSE Japan conference in Tokyo from April 24-26, 2013 to discuss how Patheon can actively support pharmaceutical and biotech companies achieve their key development and manufacturing goals

10. Reading And Imaging Are Combined In BioTek's Revolutionary, New Cytation™3
    4/15/2013

    BioTek continues providing unique solutions and technological advancements in microplate instrumentation by proudly announcing the first combination Hybrid multi-mode microplate reader and imaging system — the Cytation™3 Cell Imaging Multi-Mode Reader! By combining multi-detection and automated digital microscopy in one instrument, cell biology researchers can now glean data-rich quantitative and qualitative information from their cells like never before.